5 juillet

Hypertension https://www.ahajournals.org/

• 11:00
  Alterations of Placental Sodium in Preeclampsia: Trophoblast Responses - Hiten D. Mistry Rahel Klossner Paula J. Scaife Nicole Eisele Lesia O. Kurlak Sampada Kallol Christiane Albrecht Carine Gennari-Moser Louise V. Briggs Fiona Broughton Pipkin Markus G. Mohaupt Department of Women and Children’s Health, School of Life Course and Population Health Sciences, King’s College London, United Kingdom (H.D.M.). Teaching Hospital Internal Medicine, Lindenhofgruppe, Switzerland (R.K., M.G.M.). Department of Nephrology and Hypertension, University of Bern, Switzerland. (R.K., N.E., C.G.-M., M.G.M.) Department for BioMedical Research, University of Bern, Switzerland. (…) Hypertension
  Hypertension, Ahead of Print. BACKGROUND:Evidence suggests that increasing salt intake in pregnancy lowers blood pressure, protecting against preeclampsia. We hypothesized that sodium (Na+) evokes beneficial placental signals that are disrupted in preeclampsia.METHODS:Blood and urine were (…) (Hypertension)

3 juillet

Hypertension https://www.ahajournals.org/

• 11:00
  High-Sensitivity Troponin T, NT-proBNP, and Cognitive Outcomes in SPRINT - Devin Haney Yuan Ma Djhenne Dalmacy Nicholas M. Pajewski Ihab Hajjar James A. de Lemos Wenxin Zhang Elsayed Z. Soliman Christie M. Ballantyne Vijay Nambi Naveed Sattar Anthony A. Killeen Joachim H. Ix Michael G. Shlipak Jarett D. Berry Simon B. Ascher Department of Internal Medicine, University of Texas at Tyler Health Science Center (D.H., D.D., J.D.B.). Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA (Y.M., W.Z.). Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC (N.M.P.). Department of Neurology, (…) Hypertension
  Hypertension, Ahead of Print. BACKGROUND:Hs-cTnT (cardiac troponin T measured with a highly sensitive assay) and NT-proBNP (N-terminal pro-B-type natriuretic peptide) may identify adults with hypertension who derive greater cognitive benefits from lower systolic blood pressure targets.METHODS:In (…) (Hypertension)
• 11:00
  Sleep Apnea, Autonomic Disturbances, and Blood Pressure Variability - Tomoyuki Tobushi John S. Floras University Health Network and Sinai Health Division of Cardiology, Toronto General Hospital Research Institute, and Lunenfeld-Tanenbaum Research Institute, Faculty of Medicine, University of Toronto, ON, Canada (T.T., J.S.F.). Department of Internal Medicine, Kyushu University, Beppu Hospital, Oita, Japan (T.T.). Hypertension
  Hypertension, Ahead of Print. Augmented blood pressure variability has emerged as a quantity predictive of adverse cardiovascular outcomes. Among the range of intrinsic and extrinsic factors shown to increase night-time, circadian, short-term, and long-term blood pressure variations, the (…) (Hypertension)

27 juin

Hypertension https://www.ahajournals.org/

• 11:00
  Clinical Validation of Carotid-Femoral Pulse Wave Velocity Measurement Using a Multi-Beam Laser Vibrometer: The CARDIS Study - Smriti Badhwar Louise Marais Hakim Khettab Federica Poli Yanlu Li Patrick Segers Soren Aasmul Mirko de Melis Roel Baets Steve Greenwald Rosa-Maria Bruno Pierre Boutouyrie PARCC INSERM, Paris, France (S.B., L.M., F.P., R.-M.B., P.B.). HEGP, APHP, Paris, France (H.K., R.-M.B, P.B.). Université Paris Cité, Faculté de Médecine, France (R.-M.B, P.B.). Photonics Research Group, Ghent University-imec, Belgium (Y.L., R.B.). Center for Nano- and Biophotonics, Ghent University, Belgium (Y.L., R.B.). IBiTech- BioMMedA, Ghent University, Belgium (P.S.). Medtronic Bakken Research Center, Maastricht, (…) Hypertension
  Hypertension, Ahead of Print. BACKGROUND:Carotid-femoral pulse wave velocity (cfPWV) is the gold standard for noninvasive arterial stiffness assessment, an independent predictor of cardiovascular disease, and a potential parameter to guide therapy. However, cfPWV is not routinely measured in (…) (Hypertension)

19 juin

Hypertension https://www.ahajournals.org/

• 11:00
  Antihypertensive Drugs for the Prevention of Atrial Fibrillation: A Drug Target Mendelian Randomization Study - Sven Geurts Martijn J. Tilly Zuolin Lu Bruno H.C. Stricker Jaap W. Deckers Natasja M.S. de Groot Clint L. Miller M. Arfan Ikram Maryam Kavousi Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, The Netherlands. (S.G., M.J.T., Z.L., B.H.C.S., J.W.D., M.A.I., M.K.) Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, The Netherlands. (N.M.S.G.) Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville (C.L.M.). Hypertension
  Hypertension, Ahead of Print. BACKGROUND:We investigated the potential impact of antihypertensive drugs for atrial fibrillation (AF) prevention through a drug target Mendelian randomization study to avoid the potential limitations of clinical studies.METHODS:Validated published single-nucleotide (…) (Hypertension)

18 juin

Hypertension https://www.ahajournals.org/

• 11:00
  Centennial Collection: From Treating Hypertension to Lowering Cardiovascular Disease Risk - Cian P. McCarthy Rod Jackson John W. McEvoy Kazem Rahimi Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston (C.P.M.). Section of Epidemiology and Biostatistics, School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, New Zealand (R.J.). Cardiology Department, University of Galway School of Medicine and National Institute for Prevention and Cardiovascular Health, Ireland (J.W.M.). Deep Medicine, Nuffield Department of Reproductive and Women’s Health, University of Oxford, United Kingdom (K.R.). Hypertension
  Hypertension, Ahead of Print. (Hypertension)
• 11:00
  Impact of Social Determinants of Health on Hypertension Outcomes: A Systematic Review - Faith E. Metlock Thomas Hinneh Chitchanok Benjasirisan Abeer Alharthi Oluwabunmi Ogungbe Ruth-Alma N. Turkson-Ocran Cheryl R. Himmelfarb Yvonne Commodore-Mensah Johns Hopkins School of Nursing, Baltimore, MD (T.H., C.B., O.O., C.R.H., Y.C.-M.). Johns Hopkins School of Medicine, Baltimore, MD (O.O., C.R.H.). Department of Medicine, Research Section, Beth Israel Deaconess Medical Center, Boston, MA (R.-A.N.T.-O.). Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (C.R.H., Y.C.-M.). Hypertension
  Hypertension, Ahead of Print. Despite ample evidence linking social determinants of health (SDoH) and hypertension outcomes, efforts to address SDoH in the context of hypertension prevention and self-management are not commensurate with the burden and impact of hypertension. To provide valuable (…) (Hypertension)

17 juin

Hypertension https://www.ahajournals.org/

• 11:00
  Chronic Hypertension: A Neglected Condition but With Emerging Importance in Obstetrics and Beyond - Justin S. Brandt Cande V. Ananth Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, NYU Langone Health, New York, NY (J.S.B.). Division of Epidemiology and Biostatistics, Department of Obstetrics, Gynecology, and Reproductive Sciences; Cardiovascular Institute of New Jersey; and Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (C.V.A.). Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ (C.V.A.). Hypertension
  Hypertension, Ahead of Print. (Hypertension)
• 11:00
  Chronic Hypertension During Pregnancy: Prevalence and Treatment in the United States, 2008–2021 - Stephanie A. Leonard Sara Siadat Elliott K. Main Krista F. Huybrechts Yasser Y. El-Sayed Mark A. Hlatky Jheanelle Atkinson Ayesha Sujan Brian T. Bateman Department of Obstetrics and Gynecology, Stanford University School of Medicine, CA. (S.A.L., E.K.M., Y.Y.E.-S.) Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, CA. (S.S., A.S., B.T.B.) Departments of Health Policy and Medicine, Stanford University School of Medicine, CA. (M.A.H.) Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s (…) Hypertension
  Hypertension, Ahead of Print. BACKGROUND:Treatment of chronic hypertension during pregnancy has been shown to reduce the risk of adverse perinatal outcomes. In this study, we examined the prevalence and treatment of chronic hypertension during pregnancy and assessed changes in these outcomes (…) (Hypertension)
• 11:00
  Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US Adults - Kendra D. Sims Pengxiao Carol Wei Joanne M. Penko Susan Hennessy Pamela G. Coxson Nita H. Mukand Brandon K. Bellows Dhruv S. Kazi Yiyi Zhang Ross Boylan Andrew E. Moran Kirsten Bibbins-Domingo Department of Epidemiology and Biostatistics, University of California San Francisco (K.D.S., P.C.W., J.M.P., S.H., P.G.C., N.H.M., R.B., K.B.-D.). Department of Epidemiology, Boston University School of Public Health, MA (K.D.S.). Department of Medicine, Division of General Medicine, Columbia University Irving Medical Center, New York, NY (B.K.B., Y.Z., A.E.M.). Richard A. and Susan F. Smith Center (…) Hypertension
  Hypertension, Ahead of Print. BACKGROUND:The 2017 American College of Cardiology/American Heart Association blood pressure guideline classified 31 million US adults as having stage 1 hypertension and recommended clinicians provide counseling on behavioral change to the low-risk portion of this (…) (Hypertension)
• 11:00
  Immune Mechanisms in Hypertension - David G. Harrison David M. Patrick Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (D.G.H., D.M.P.). Department of Veterans Affairs, Nashville, TN (D.M.P.). Hypertension
  Hypertension, Ahead of Print. It is now apparent that immune mediators including complement, cytokines, and cells of the innate and adaptive immune system contribute not only to blood pressure elevation but also to the target organ damage that occurs in response to stimuli like high salt, (…) (Hypertension)
• 11:00
  Relationship Between Sarcopenia and Intensive Blood Pressure Control Efficacy and Safety: A Secondary Analysis of SPRINT - Saeid Mirzai Ian Persits Richard Kazibwe Mohanad Gabani Austin Seals Matthew J. Singleton Rishi Rikhi Parag Chevli Salvatore Carbone W.H. Wilson Tang Joseph Yeboah Jeff D. Williamson Dalane W. Kitzman David Herrington Michael D. Shapiro Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston Salem, NC. (S.M., M.G., A.S., R.R., J.Y., D.W.K., D.H., M.D.S.) Section on Hospital Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston Salem, NC. (R.K., P.C.) Section on Gerontology and Geriatric (…) Hypertension
  Hypertension, Ahead of Print. BACKGROUND:Sarcopenia and hypertension are independently associated with worse cardiovascular disease (CVD) risk and survival. While individuals with sarcopenia may benefit from intensive blood pressure (BP) control, the increased vulnerability of this population (…) (Hypertension)

12 juin

Hypertension https://www.ahajournals.org/

• 11:00
  Alcohol Intake and Risk of Hypertension: A Systematic Review and Dose-Response Meta-Analysis of Nonexperimental Cohort Studies - Marta Cecchini Tommaso Filippini Paul K. Whelton Inga Iamandii Silvia Di Federico Giuseppe Boriani Marco Vinceti CREAGEN - Environmental, Genetic and Nutritional Epidemiology Research Center, Section of Public Health, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy. (M.C., T.F., I.I., S.D.F., M.V.) Unit of Cardiology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy. (G.B.) School of Public Health, University of California Berkeley (T.F.). Department of Epidemiology, Tulane (…) Hypertension
  Hypertension, Ahead of Print. BACKGROUND:Alcohol consumption has been associated with higher blood pressure and an increased risk of hypertension. However, the possible exposure thresholds and effect-modifiers are uncertain.METHODS:We assessed the dose-response relationship between usual alcohol (…) (Hypertension)
• 08:00
  To Screen or Not to Screen for Atrial Fibrillation in Patients With Hypertension, That Is Not the Question - Elsayed Z. Soliman Lin Yee Chen Epidemiological Cardiology Research Center, Department of Internal Medicine, Section on Cardiovascular Medicine, Wake Forest School of Medicine, Winston Salem, NC. Lillehei Heart Institute and Department of Medicine, University of Minnesota Medical School, Minneapolis. Hypertension
  Hypertension, Volume 81, Issue 7, Page 1489-1490, July 1, 2024. (Hypertension)
• 08:00
  In Memoriam: Stephen C. Textor - Lilach O. Lerman Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN. Hypertension
  Hypertension, Volume 81, Issue 7, Page e74-e76, July 1, 2024. (Hypertension)

10 juin

Hypertension https://www.ahajournals.org/

• 11:00
  PD-1/PD-L1 Provides Protective Role in Hypoxia-Induced Pulmonary Vascular Remodeling - Lei Wang Mi Mu Yu Guo Jing Huang Ruoyang Zhang Muzhi Zhang Yue Hu Yanhua Wang Zhenqiang Gao Lin Liu Wang Wang Yuli Cheng XinPing Zhu Jie Liu Wei Wang Sun Ying Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi’an Jiaotong University, Shaanxi, China (L.W.). Department of Respiratory and Critical Care Medicine, The Eighth Medical Center of Chinese PLA General Hospital, Beijing, China (M.M.). Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. (Y.G., M.Z., Y.H., Z.G., J.L., Wei Wang, S.Y.) Department (…) Hypertension
  Hypertension, Ahead of Print. BACKGROUND:Hypoxia-induced pulmonary hypertension (HPH) is a T helper 17 cell response-driven disease, and PD-1 (programmed cell death 1)/PD-L1 (programmed cell death-ligand 1) inhibitor–associated pulmonary hypertension has been reported recently. This study is (…) (Hypertension)
• 11:00
  Positive Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Hypertension May Be Attenuated by Endogenous Sex Hormones: A Nationally Representative Cross-Sectional Study - Bing Wu Nan Sheng Zheng Li Jinghua Wang Saisai Ji Feng Zhao Yitao Pan Yingli Qu Yuan Wei Linna Xie Yawei Li Xiaojian Hu Changzi Wu Zheng Zhang Yidan Qiu Xulin Zheng Wenli Zhang Xuehua Hu Haocan Song Jiayi Cai Zhaojin Cao John S. Ji Yuebin Lv Jiayin Dai Xiaoming Shi China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing (B.W., Z.L., S.J., F.Z., Y.Q., Y.W., L.X., Y.L., X.H., C.W., Z.Z., Y.Q., X.Z., W.Z., X.H., H.S., J.C., Z.C., Y.L., X.S.). State Environmental Protection Key (…) Hypertension
  Hypertension, Ahead of Print. BACKGROUND:Perfluoroalkyl and polyfluoroalkyl substance (PFAS) has endocrine-disrupting properties and may affect blood pressure. Endogenous hormones also play a crucial role in the progression of hypertension. However, their interaction with hypertension remains to (…) (Hypertension)

6 juin

Hypertension https://www.ahajournals.org/

• 11:00
  IL-1R–Mediated Activation of Renal Sensory Nerves in DOCA-Salt Hypertension - Daniel Baumann Dusty Van Helden Louise C. Evans Lucy Vulchanova Alex Dayton John W. Osborn Graduate Program in Integrative Biology and Physiology, University of Minnesota, Minneapolis. (D.B.) Department of Surgery, University of Minnesota, Minneapolis. (D.B., D.V.H., L.C.E., J.W.O.) Department of Neuroscience, University of Minnesota, Minneapolis. (L.V.) Division of Nephrology and Hypertension, University of Minnesota, Minneapolis. (A.D.) Hypertension
  Hypertension, Ahead of Print. BACKGROUND:Clinical trials of renal denervation for the treatment of hypertension have shown a variety of off-target improvements in conditions associated with sympathetic overactivity. This may be due to the ablation of sympathoexcitatory afferent renal nerves, (…) (Hypertension)
• 11:00
  Stroke Incidence in Patients With Hypertension According to Cardiorespiratory Fitness - Peter Kokkinos Charles Faselis Andreas Pittaras Immanuel Babu Henry Samuel Carl J. Lavie Robert Ross Michael LaMonte Barry A. Franklin Charalampos Grassos Edward Zaprini Rayelynn Murphy Jonathan Myers Veterans Affairs Medical Center, Washington, DC (P.K., C.F., A.P., R.M.). Department of Kinesiology and Health, School of Arts and Sciences, Rutgers University, New Brunswick, NJ (P.K.). George Washington University School of Medicine and Health Sciences, Washington, DC (P.K., C.F., A.P.). War Related Illness and Injury Study Center, Veterans Affairs Medical Center, Washington, DC (I.B.H.S.). (…) Hypertension
  Hypertension, Ahead of Print. BACKGROUND:Hypertension and physical inactivity are risk factors for stroke. The effect of cardiorespiratory fitness (CRF) on stroke risk in patients with hypertension has not been assessed. We evaluated stroke incidence in patients with hypertension according to (…) (Hypertension)